胸腺切除后继发再生障碍性贫血一例
本文报道一例60岁女性重症肌无力患者,CT偶然发现胸腺瘤,胸腺切除后重症肌无力缓解,但出现对粒细胞集落刺激因子、环孢素和马抗胸腺细胞球蛋白耐药的再生障碍性贫血,接受异基因干细胞移植后因并发症死亡。胸腺瘤可致再生障碍性贫血且胸腺切除可治愈,但反向现象极罕见。
要点
- 胸腺切除后新发再生障碍性贫血极罕见,需警惕。
- 该例再生障碍性贫血对粒细胞集落刺激因子、环孢素和马抗胸腺细胞球蛋白耐药。
- 异基因干细胞移植后患者仍因并发症死亡。
核心结论
- 胸腺切除治疗胸腺瘤相关重症肌无力后,极罕见地继发对多种免疫抑制治疗耐药的再生障碍性贫血。
研究设计与样本
- 单例病例报告:60岁女性,重症肌无力,CT偶然发现胸腺瘤。
主要发现
- 胸腺切除后重症肌无力缓解,但出现再生障碍性贫血,对粒细胞集落刺激因子、环孢素和马抗胸腺细胞球蛋白治疗耐药。
- 患者接受异基因干细胞移植,后因并发症死亡。
临床怎么用
- 胸腺切除后需监测血液学异常,新发再生障碍性贫血应识别为罕见但严重的并发症。
局限性
- 单例病例报告,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is a well-described phenomenon in the literature that a thymoma can lead to aplastic anemia, and that a thymectomy can be curative for to aplastic anemia. However, the opposite is extremely rare. We present an unusual case of a 60-year-old woman with myasthenia gravis, who was diagnosed with an incidental thymoma found on computerized tomography. Resection of the thymoma treated her myasthenia gravis but led to an aplastic anemia resistant to granulocyte colony-stimulating factor, cyclosporin, and horse antithymocyte globulin treatment. The patient received an allogenic stem cell transplant but unfortunately passed away because of complications.
引用
- Franchi T, Rao J. Aplastic Anemia Secondary to Thymectomy in a Patient With Myasthenia Gravis. Ann Thorac Surg. 2020. PMID: 32135152. doi:10.1016/j.athoracsur.2020.01.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。